Thomas V. Inglesby, M.D., M.P.H. (Planning Committee Chair), is the director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, a nongovernmental academic organization dedicated to protecting people’s health from the consequences of epidemics and disasters and ensuring that communities are resilient to those challenges. He is a professor of medicine and public health at the University of Pittsburgh. Dr. Inglesby’s work is internationally recognized in the fields of public health preparedness, pandemic flu and epidemic planning, and biosecurity. He is the chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, U.S. Centers for Disease Control and Prevention (CDC). He is also the chair of the National Advisory Council of the Robert Wood Johnson Foundation’s National Health Security Preparedness Index. He was a member of the External Laboratory Safety Workgroup appointed by the CDC Director that examined biosafety practices of CDC, the National Institutes of Health (NIH), and the U.S. Food and Drug Administration. He was a member of the 2016 Working Group assessing U.S. biosecurity on behalf of the President’s Council of Advisors on Science and Technology. He has served on committees of the Defense Science Board; the National Academies of Sciences, Engineering, and Medicine; the Institute of Medicine; and in an advisory capacity to NIH, the Biomedical Advanced Research and Development Authority, the U.S. Department of Homeland Security, and the Defense Advanced Research Projects Agency. During the past 17 years, Dr. Inglesby has authored or co-authored more than 100 peer-reviewed articles, reports, and editorials on a range of issues related to health security and preparedness for epidemics and disasters. He is the
editor-in-chief of the journal Health Security, which he helped to establish 13 years ago as the first peer-reviewed journal in its field. He was a principal editor of the Journal of the American Medical Association’s book Bioterrorism: Guidelines for Medical and Public Health Management. He has been invited to brief White House officials from the past three presidential administrations on national biosecurity challenges and priorities, and he has delivered congressional testimony on a number of issues related to public health preparedness and biosecurity. He is regularly consulted by major news outlets for his expertise. He is a member of the board of directors of PurThread, a company dedicated to developing antimicrobial textiles. Dr. Inglesby completed his internal medicine and infectious diseases training at the Johns Hopkins University School of Medicine, where he also served as assistant chief of service in 1996–1997. Dr. Inglesby received his M.D. from Columbia University College of Physicians and Surgeons and his B.A. from Georgetown University. He continues to see patients in a weekly infectious disease clinic.
David M. Abramson, Ph.D., M.P.H., is the founding director of New York University’s (NYU’s) Program on Population Impact, Recovery and Resiliency (PiR2), a faculty member of NYU’s College of Global Public Health, and an associate faculty member of the NYU Medical School’s Department of Population Health. Prior to joining the NYU faculty in 2014, Dr. Abramson was the deputy director at Columbia University’s National Center for Disaster Preparedness at the Earth Institute. Dr. Abramson has led a number of major research studies examining the long-term impacts of disasters on communities and on vulnerable populations, including children. These studies include the longitudinal Gulf Coast Child and Family Health Study, post–Hurricane Katrina, which has recently received funding from the National Institutes of Health (NIH) to look at recovery 10 years after the storm, and the Sandy Child and Family Health Study currently being conducted in partnership with Rutgers University with funding from the New Jersey Department of Health. Dr. Abramson is also the co-investigator of the NIH-funded Women’s and Their Children’s Health Study, exploring the impact of the Deepwater Horizon oil spill on children’s long-term health in collaboration with Louisiana State University. Among his research-to-action initiatives, Dr. Abramson is the co-founder and co-director of the SHOREline youth empowerment project with Colorado State University’s Dr. Lori Peek, a curricular project-based learning program presently operating in a number of Gulf Coast and New York City high schools. In addition to the disaster recovery work related to Hurricanes Katrina and Sandy and the Deepwater Horizon oil spill, Dr. Abramson has studied short-term post-tornado community recovery in Joplin, Missouri, disaster recovery planning in four mid-sized U.S. cities, risk communication strategies, and organiza-
tional and attitudinal aspects of disaster preparedness. Dr. Abramson received his Ph.D. in sociomedical sciences from Columbia University, with a specialization in political science, and an M.P.H. from Columbia University as well. Over the past 25 years he has conducted research on HIV/AIDS, public health systems research, and civic engagement policy and practice. Prior to entering the field of public health, Dr. Abramson spent a decade as a national magazine journalist, having worked at or written for such publications as Rolling Stone, Esquire, and Outside magazines, among others.
David Blazes, M.D., M.P.H., joined the Bill & Melinda Gates Foundation in May 2016 after serving as a physician epidemiologist in the U.S. Navy. Among many career highlights, he and his family spent 4 years in Peru where he directed the Emerging Infections Department at Naval Medical Research Unit Six. His work there involved developing disease surveillance systems in resource-limited settings, working with local officials in responding to outbreaks, and characterizing several novel pathogens. After returning to Washington, DC, he directed the U.S. Department of Defense’s (DoD’s) global disease surveillance efforts and contributed to DoD’s global health security work. He served as the chief advisor to the Navy Surgeon General on Infectious Diseases as well as on the National Academies of Sciences, Engineering, and Medicine’s Forum on Microbial Threats. His academic work has appeared in Science, Nature, and The Lancet, and he recently edited a textbook on technological considerations in disease surveillance. Dr. Blazes graduated from the U.S. Naval Academy, did his medical training at Johns Hopkins University, and then did his residency and infectious diseases fellowship at the Bethesda Naval Hospital.
Margaret L. Brandeau, Ph.D., is the Coleman F. Fung professor of engineering and professor of medicine (by courtesy) at Stanford University. Her research focuses on the development of applied mathematical and economic models to support health policy decisions. Her recent work has examined HIV and drug abuse prevention and treatment programs, programs to control the spread of hepatitis B virus, and preparedness plans for bioterror response. She currently serves on the Board of Scientific Counselors, Office of Public Health Preparedness and Response, U.S. Centers for Disease Control and Prevention (CDC), as well as the National Academies of Sciences, Engineering, and Medicine’s Standing Committee for the Centers for Disease Control and Prevention Division of the Strategic National Stockpile. In 2012–2013 she served on the Board of Scientific Counselors/National Biodefense Science Board Working Group for the Strategic National Stockpile Review 20/20 and served on the Institute of Medicine Committee on Prepositioned Medical Countermeasures in 2011. She has published 2 books and more than 100 peer-reviewed papers and has received numerous
awards for her research and teaching. Professor Brandeau earned a B.S. in mathematics and an M.S. in operations research from the Massachusetts Institute of Technology and a Ph.D. in engineering-economic systems from Stanford University.
Kathryn Brinsfield, M.D., M.P.H., served as the assistant secretary of Health Affairs and chief medical officer for the U.S. Department of Homeland Security’s (DHS’s) Office of Health Affairs (OHA) until January 2017. She began her service with DHS in July 2008 and previously served as the director of the Division of Workforce Health and Medical Support within OHA. Before joining DHS, Dr. Brinsfield worked for various organizations, including Massachusetts Homeland Security Boston Emergency Services (EMS), Boston Metropolitan Medical Response System (MMRS), and the del Valle Emergency Preparedness Training Institute. Dr. Brinsfield left Boston as an associate professor at the Boston University Schools of Medicine and Public Health with 13 years of experience as an attending physician at Boston City Hospital/Boston Medical Center. She graduated with honors from Brown University, received her M.D. from Tufts School of Medicine, and received her M.P.H. from Boston University. She completed her residency in emergency medicine at Cook County Hospital in Chicago and her EMS fellowship at Boston EMS. She worked for Boston EMS as the director of research, training and quality improvements, medical director for special operations, and associate medical director. She chaired the American College of Emergency Physician’s Disaster Committee, co-chaired the Massachusetts State Surge Committee, assisted in the creation of the Massachusetts Alternate Standards of Care Committee, and was the commander of the Massachusetts-1 Disaster Medical Assistance Team and a supervisory medical officer for the International Medical and Surgical Response Team, which responded to the September 11, 2001, attacks.
Daniel Dodgen, Ph.D., is the director for At-Risk Individuals, Behavioral Health, and Community Resilience in the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS). His office focuses on ensuring that children, at-risk individuals, behavioral health, and community resilience are integrated into federal public health and medical preparedness and response activities. Before joining HHS, Dr. Dodgen served as the special assistant to the CEO and senior legislative and federal affairs officer at the American Psychological Association (APA) following a fellowship with the U.S. House of Representatives Committee on Education. He has served on multiple federal advisory groups and authored numerous articles and book chapters on emergency preparedness, psychology, and public policy. Dr. Dodgen is a trained American Red Cross disaster mental health worker and was part
of the response to the 1992 Los Angeles riots, the 1994 Los Angeles earthquakes, the 1995 Oklahoma City bombings, and the September 11, 2001, Pentagon attack. Following the Pentagon attack, Dr. Dodgen co-founded the Metropolitan Washington Mental Health Community Response Coalition and served as its chairman. He received the American Psychological Association 2005 Early Career Award for Contribution to Psychology in the Public Interest and was elected a fellow of APA in 2012. He is a licensed clinical psychologist in the District of Columbia.
David T. Dyjack, Dr.P.H., Ms.P.H., is the executive director and CEO of the 5,000-member National Environmental Health Association (NEHA), a position he has held since May 2015. He contributes to many national and international advisory committees in public health, covering a broad menu of capacity-building initiatives, including adult continuing professional education, formal academic degrees, emergency preparedness, informatics, and environmental health. Under his leadership, NEHA has established a presence in Washington, DC, in support of efforts to influence national policy. Dr. Dyjack earned a doctorate in public health from the University of Michigan, an Ms.P.H. from the University of Utah, and is a board certified industrial hygienist (CIH).
David Eisenman, M.D., Ms.H.S., is the professor in residence at the David Geffen School of Medicine and the Fielding School of Public Health at the University of California, Los Angeles (UCLA), where he is the director of the Center for Public Health and Disasters. Dr. Eisenman’s training is in internal medicine, public health, and health services research. He has been funded by the National Institutes of Health, National Science Foundation, U.S. Centers for Disease Control and Prevention, National Institute of Justice, Office of the Assistant Secretary for Preparedness and Response, U.S. Forest Service, Robert Wood Johnson Foundation, and the U.S. Department of Homeland Security to study community resilience to disasters, climate change, violence and the health effects of disasters and trauma. Recent studies investigated the interactions of social and built-environment predictors of heatwave mortality and morbidity, the mortality associated with wintertime extreme heat in Los Angeles, organizational networks in disasters, behavioral responses to wireless emergency alerts, climate change policy in public health, social cohesion and health, wildfires and mental health, and improving treatment for posttraumatic stress disorder in public safety-net clinics. In 2012, the Los Angeles County Department of Public Health appointed Dr. Eisenman as the preparedness science officer for the Emergency Preparedness and Response Program. In 2015, the U.S. National Institute of Standards and Technology appointed Dr. Eisenman to chair the Social and Economic Resilience Committee of the Community Resilience Planning
Guide. Dr. Eisenman is an associate natural scientist at RAND. He holds a board certification in internal medicine and he cares for patients at the UCLA Medical Center.
Aaron Firoved, Ph.D., serves as the director for the National Biosurveillance Integration Center. In this position, he enables a collaboration of federal partners to integrate information about threats to human, animal, plant, and environmental health from diverse sources to develop a more comprehensive picture of the biological threat landscape and support better response decisions. Dr. Firoved also serves as the senior biodefense advisor to the Assistant Secretary for Health Affairs and the chief medical officer of the U.S. Department of Homeland Security. Prior to joining the Office of Health Affairs in April 2012, Dr. Firoved worked for the U.S. Senate Homeland Security and Governmental Affairs Committee where he was responsible for the Committee’s programmatic and budgetary oversight of its biodefense, disaster medical response, and medical countermeasure portfolios. Dr. Firoved conducted postdoctoral research studying anthrax pathology at the National Institutes of Health. He received his Ph.D. in microbiology and immunology through studies of bacterial pathogenesis associated with cystic fibrosis disease from the University of Michigan and his B.S. in microbiology from the University of Washington.
Dylan George, Ph.D., is the associate director of B.Next at In-Q-Tel (IQT), a private, nonprofit strategic investment firm that effectively brings leading edge technological innovation to departments and agencies within the U.S. government through targeted support of venture-backed start-up firms. Within IQT, Dr. George helped define and establish a strategic IQT initiative, B.Next, that aims to identify opportunities and risks in the rapidly advancing fields of biological sciences. For B.Next, Dr. George provides strategic science and technical vision to strengthen the capacity within the United States to counter biological threats, specifically those from infectious disease epidemics, whether natural, accidental, or intentional. Prior to joining IQT, Dr. George served Dr. John Holdren, assistant to the President for Science and Technology and director of the White House Office of Science and Technology Policy (OSTP), as a senior advisor for biological threat defense. Among other responsibilities at OSTP, Dr. George provided technical expertise and interagency coordination supporting the response to the Ebola outbreak in West Africa. From 2013–2014, Dr. George worked in the U.S. Department of Health and Human Services within the Biomedical Advanced Research and Development Authority where he led a team that developed analytical approaches to assess risks from emerging infectious diseases and other mass casualty events. From 2009–2013, Dr. George worked within the U.S. Department of Defense on anticipating and assess-
ing infectious disease risks that would impact mission readiness and force health protection. Dr. George worked at the National Science Foundation (NSF) within the Divisions of Biological Infrastructure and Environmental Biology. While at NSF, Dr. George supported, among other activities, the National Ecological Observatory Network and the Ecology of Infectious Diseases program. Dr. George received his Ph.D. from Colorado State University and focused on quantitative analytical approaches for considering how clinically severe pathogens (e.g., Yersinia pestis, rabies) persist within wildlife populations.
Jesse L. Goodman, M.D., M.P.H., is a professor of medicine at Georgetown University, where he directs the Center on Medical Product Access, Safety and Stewardship (COMPASS), which focuses on informing science-based policy to address emerging public health needs. He is an attending physician in infectious diseases at Georgetown University, Washington, DC; Veterans Affairs; and Walter Reed National Military Medical Centers. COMPASS’s current activities include being part of the National Capital Region Coalition Against Antimicrobial Resistance and mapping the global spread of carbapenem-resistant enterobacteriaceae. Until February 2014 he was the chief scientist of the U.S. Food and Drug Administration (FDA), a position he assumed in 2009 along with deputy commissioner for science and public health (2009–2012) and was responsible for strategic leadership of FDA’s crosscutting scientific and public health efforts. He led the 2009 H1N1 pandemic response and medical countermeasure review for FDA, also serving as a member of the U.S. Department of Health and Human Services senior leadership team and the White House Medical Countermeasure Review Group. From 2003 to 2009 he directed FDA’s Center for Biologics Evaluation and Research. As the senior advisor to the Commissioner from 1998–1999, he co-chaired the U.S. Task Force on Antimicrobial Resistance, producing the first Public Health Action Plan to Combat Antimicrobial Resistance. He served on the Decade of Vaccines Research and Development Group and on numerous U.S. Centers for Disease Control and Prevention, National Institutes of Health, U.S. Department of Defense, and World Health Organization (WHO) Advisory Committees, including the WHO Ebola Vaccine Working Group. He currently serves as president and trustee of the U.S. Pharmacopeial Convention (a nonprofit organization that sets standards for medicines and promotes global pharmaceutical quality). He is also on the Scientific Advisory Board of the Coalition on Epidemic Preparedness Innovation and is an independent scientific/medical member of the board of GlaxoSmithKline. Previously, he was the professor and chief of infectious diseases at the University of Minnesota, where his laboratory first isolated the emerging tick borne pathogen Anaplasma phagocytophilum. A graduate of Harvard, he received his M.D. from the Albert Einstein
College of Medicine and did residency and fellowship training at the Hospital of the University of Pennsylvania and at University of California, Los Angeles, where he was the chief medical resident. He is board certified in internal medicine, infectious diseases, and oncology and was elected to the American Society for Clinical Investigation and to the National Academy of Medicine.
Doug Halley is the director of transportation for CrossTown Connect (CtC) and the Town of Acton. CtC is an innovative public–private partnership Transportation Management Association. CtC provides suburban transportation services that help seniors, people with disabilities, commuters, reverse commuters, and special populations to arrive at their destinations. In 2015 CtC was recognized by the International City/County Managers Association for its achievements. Mr. Halley provides the same services for the Town of Acton, which is one of the members of CtC. For his work in transportation, he has received awards from the 495 MetroWest Partnership, Community Health Network Area 15, and the Local Officials Human Services Council. In 2015 he retired as health director for the Town of Acton after 28 years of service. As health director, he was responsible for a visiting nurse service, a 300,000-gallon per day wastewater treatment plant, and stormwater compliance, as well as all public health programs. As director, he implemented a unique funding system for the programs which relied primarily on fees for services. He was chairman of Massachusetts Preparedness Region 4A for 3 years. He developed and implemented an educational program for the Pine Hawk Archaeological site, which received an award from the Massachusetts Historical Commission. He was recognized by the Massachusetts Health Officers Association with the Michael Saraco award.
Laura Hanen, M.P.P., is the chief of government affairs for the National Association of County & City Health Officials (NACCHO) in Washington, DC. The National Association of County & City Health Departments is the voice of the approximately 2,800 local health departments across the country. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. Ms. Hanen’s primary responsibilities are to oversee policy development, federal lobbying, and the Big Cities Health Coalition. Ms. Hanen is also a member of NACCHO’s executive management team. Ms. Hanen joined NACCHO in March 2011. Prior to coming to NACCHO, Ms. Hanen was the director of government relations for the National Alliance of State and Territorial AIDS Directors for 11 years, as well as the senior lobbyist for the American Congress of Obstetricians and Gynecologists. Ms. Hanen was a legislative assistant for Congressman Rick Boucher of the Ninth District of Virginia and a legislative assistant
in the government relations department of the Biotechnology Innovation Organization. Ms. Hanen received her bachelor’s degree from Earlham College in Richmond, Indiana, and a master’s degree in public policy from Georgetown University in Washington, DC.
Dan Hanfling, M.D. (Forum Co-Chair), is a consultant on emergency preparedness, response, and crisis management. He is a contributing scholar at the Johns Hopkins Bloomberg School of Public Health Center for Health Security, clinical professor of emergency medicine at The George Washington University, and adjunct faculty at the George Mason University School of Public Policy. He also serves as a special advisor within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, focused chiefly on the National Hospital Preparedness Program. Dr. Hanfling spent 18 years as principal consultant to the Inova Health System (Falls Church, Virginia) on matters related to emergency preparedness and response. He continues to practice emergency medicine at Inova Fairfax Regional Trauma Center, and is an operational medical director for a regional helicopter emergency medical services service. He was instrumental in founding one of the nation’s first health care coalitions, the Northern Virginia Hospital Alliance, created in October 2002. His areas of expertise include biodefense and mass casualty management, catastrophic disaster response planning with particular emphasis on scarce resource allocation, and the nexus between health care system planning and emergency management. In addition to his hospital and emergency medical service clinical responsibilities, he serves as a medical team manager for the Fairfax County–based Federal Emergency Management Association and U.S. Agency for International Development–sanctioned international urban search and rescue team (Virginia Task Force-1, USA-1), and has responded to catastrophic disaster events across the globe. Dr. Hanfling received his undergraduate degree in political science from Duke University, including a general course at the London School of Economics, and completed his medical degree at Brown University. He completed his internship in internal medicine at Brown University and his emergency medicine training at the combined The George Washington University and Georgetown University residency program. He has been board certified in emergency medicine since 1997.
John L. Hick, M.D., is a faculty emergency physician at Hennepin County Medical Center (HCMC) and an associate professor of emergency medicine at the University of Minnesota. He serves as the associate medical director for Hennepin County emergency medical services and medical director for emergency preparedness at HCMC. He is the medical advisor to the Minneapolis/St. Paul Metropolitan Medical Response System. He also
serves the Minnesota Department of Health as the medical director for the Office of Emergency Preparedness and medical director for Hospital Bioterrorism Preparedness. He is the founder and past chair of the Minneapolis/St. Paul Metropolitan Hospital Compact, a 29-hospital mutual aid and planning group active since 2002. He is involved at many levels of planning for surge capacity and adjusted standards of care and traveled to Greece to assist in health care system preparations for the 2004 Summer Olympics as part of a 15-member team from the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services. He is a national speaker on hospital preparedness issues and has published numerous papers dealing with hospital preparedness for contaminated casualties, personal protective equipment, and surge capacity.
Jean Hu-Primmer, M.S., is currently the senior advisor for chemical, biological, radiological, or nuclear and pandemic influenza in the U.S. Food and Drug Administration’s (FDA’s) Office of Counterterrorism and Emerging Threats (OECT). Ms. Hu-Primmer has 20+ years of federal experience within the U.S. Department of Health and Human Services. Her past achievements include the development, implementation and management of OCET’s Medical Countermeasures Initiative Regulatory Science Program, which fosters high-priority science and technology projects that facilitate FDA review of medical countermeasures against chemical, biological, radiological, and nuclear and emerging disease threats. Most recently, as a health scientist and project officer in the Influenza Division at the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response, Ms. Hu-Primmer served as the program champion for BARDA’s universal influenza vaccine program initiative, providing subject-matter expertise in product and clinical development. Ms. Hu-Primmer also led BARDA’s continuous manufacturing innovations program, a joint initiative with FDA’s Emerging Technologies Team, and worked closely with the Advanced Manufacturing National Program Office to launch the first Commerce-sponsored Manufacturing USA Institute for biopharmaceutical manufacturing. During the early years of her tenure within the federal government, Ms. Hu-Primmer worked as a research scientist both at FDA’s Center for Biologics Evaluation and Research and the U.S. Centers for Disease Control and Prevention in the area of influenza vaccine development, immunology, and viral pathogenesis, including research on the highly pathogenic avian influenza A/H5N1. Ms. Hu-Primmer also spent time in her federal career as a regulatory affairs scientist for the National Institutes of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases where her responsibility included management of the entire extramural influenza vaccine clinical trials regulatory portfolio for the Division. Ms. Hu-Primmer holds a B.S. in
microbiology from Cornell University and an M.S. in molecular and cellular biology from the University of West Florida.
Rebecca Katz, Ph.D., M.P.H., is an associate professor of international health and co-director of the Center for Global Health Science and Security at Georgetown University. Prior to coming to Georgetown, she spent 10 years at The George Washington University as faculty in the Milken Institute School of Public Health. Her research is focused on global health security, public health preparedness, and health diplomacy. Since 2007, much of her work has been on the domestic and global implementation of the International Health Regulations. Since 2004, Dr. Katz has been a consultant to the U.S. Department of State, working on issues related to the Biological Weapons Convention, pandemic influenza, and disease surveillance. Dr. Katz received her undergraduate degree from Swarthmore College, an M.P.H. from Yale University, and a Ph.D. from Princeton University.
Michael G. Kurilla, M.D., Ph.D., is the director of the Office of Biodefense Research Affairs and associate director for Biodefense Product Development for the National Institute of Allergy and Infectious Diseases (NIAID). His primary role is to provide overall institute coordination for the product development of medical countermeasures against bioterror threats. At the University of Virginia, he was an assistant professor of pathology as well as co-director of the Laboratory of Molecular Diagnostics and associate director for clinical microbiology. Dr. Kurilla moved to the private sector working in anti-infective drug development at Dupont Pharmaceuticals, Bristol-Myers Squibb, and Wyeth. He subsequently joined NIAID as a medical officer. In 2005, he was named to his current positions within NIAID. He received his undergraduate degree in chemistry from the California Institute of Technology. He earned his M.D. and Ph.D. from Duke University. Dr. Kurilla took his postgraduate medical training in pathology at the Brigham & Women’s Hospital in Boston, Massachusetts, and a postdoctoral fellowship with Dr. Elliott Kieff at the Harvard Medical School as a Life Sciences Research Foundation fellow, followed by a Markey Scholar Award.
Deborah A. Levy, Ph.D., M.P.H., is the professor and interim chair of the Department of Epidemiology in the College of Public Health at the University of Nebraska Medical Center. Dr. Levy is a retired Captain with the U.S. Public Health Service and stationed at the U.S. Centers for Disease Control and Prevention (CDC) for the past 20 years. Most recently, she focused on leading the Healthcare Preparedness Activity, a program she developed beginning in 2003 while in the Division of Healthcare Quality Promotion, which concentrates on all-hazards preparedness and emergency response of
the health care system. Her primary interest has been working with communities to assist them with integrating planning of public health, health care, emergency medical services, and emergency management sectors to improve responses to public health emergencies. Dr. Levy’s career at CDC began in 1996 as an epidemic intelligence service officer in the Division of Parasitic Diseases, where she studied foodborne diseases such as Cyclosporiasis and oversaw the National Waterborne Diseases Outbreak Surveillance System. Among other roles, Dr. Levy served as acting director of the Division of Strategic National Stockpile. Throughout her time at CDC, Dr. Levy responded to many incidents including severe acute respiratory syndrome, Hurricane Katrina, the 2009 H1N1 influenza pandemic, Middle East respiratory syndrome, Ebola, and Zika. Prior to CDC, Dr. Levy was involved in National Institutes of Health studies in neuro and cancer epidemiology, as well as HIV wasting syndrome. She earned a B.A. in psychology and an M.P.H. in epidemiology from the University of California, Los Angeles, and a Ph.D. in epidemiology from the Johns Hopkins University School of Hygiene and Public Health.
Dara Alpert Lieberman, M.P.P., is the senior government relations manager at Trust for America’s Health (TFAH). She works with the director of government relations to advance TFAH’s agenda with federal, state, and local governments. At TFAH, Ms. Lieberman leads the organization’s advocacy around infectious disease prevention, disease surveillance, and strengthening the nation’s public health emergency preparedness and response capabilities. Ms. Lieberman previously served as a legislative representative for the American Counseling Association, where she advocated for mental health access issues. In recent years, Ms. Lieberman has also worked on children’s health care access for the Children’s Defense Fund and served as a staff member for the Senate Committee on Armed Services. In addition to working directly with policy makers, she has organized grassroots advocacy efforts at the national and state level. She secured an M.P.P. from the Gerald R. Ford School of Public Policy at the University of Michigan. She graduated magna cum laude with a B.A. in public policy studies from Duke University. Ms. Lieberman currently serves on the board of Healthcare Ready, a nonprofit that works to protect patient access to health care in the face of disaster through collaboration with public health and health care.
Emily Lord, M.P.A., is the executive director of Healthcare Ready. She oversees programs that help strengthen health care supply chains through collaboration with public health and private sectors before, during, and after disasters and pandemic outbreaks. As the convener of industry and government, Healthcare Ready safeguards patient health by providing solutions to
critical problems, and provides best practices for health care preparedness and response. Ms. Lord has led Healthcare Ready through multiple natural disasters, including Hurricane Sandy. Ms. Lord also serves as the chair of the U.S. Department of Health and Human Services’ Critical Infrastructure Protection Program’s lab, blood and pharmacy subsector. Ms. Lord holds an M.P.A. from The George Washington University and a B.A. from the University of Wisconsin–Madison.
Carmen Maher, M.A., Rear Admiral (RADM), is a nurse officer in the U.S. Public Health Service Commissioned Corps. She is an assistant surgeon general and is currently serving as the acting assistant commissioner for counterterrorism policy and acting director of the Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist, U.S. Food and Drug Administration (FDA). In this capacity, RADM Maher is responsible for providing leadership, coordination, and oversight for FDA’s national and global health security, counterterrorism, and emerging threat portfolios. She serves as FDA’s point of entry on policy and planning matters concerning counterterrorism and emerging threats, and collaborates across the U.S. government and internationally on actions to advance global health security and U.S. national security. RADM Maher works in collaboration with other U.S. government agencies to define and prioritize requirements for medical countermeasures (MCMs) to respond to public health emergencies, coordinate research for evaluating MCMs, set strategies for deployment and use of MCMs, and facilitate access to MCMs during public health emergencies. RADM Maher also leads FDA’s Medical Countermeasures Initiative, a key component of a broad U.S. government program to improve the U.S. capacity to respond quickly and effectively to public health emergencies. RADM Maher has supported MCM and counterterrorism programs at FDA since 2006. From 2002–2006, she served as nurse officer and lead regulatory officer for pre-clinical and early clinical development of infectious disease vaccines and therapeutics at the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases. RADM Maher began her nursing career in 1993 as an Ensign in the U.S. Navy, assigned to the National Naval Medical Center in Bethesda, Maryland. She has more than 20 years of experience in nursing, regulatory affairs, clinical trials and medical product development, public health, and emergency response. RADM Maher earned an associate’s degree and B.S.N. from the University of Puerto Rico. She earned an M.A. in national security and strategic studies with highest distinction from the U.S. Naval War College in Rhode Island and holds a regulatory affairs certification in U.S. health care product regulations.
Gregg Margolis, Ph.D., is the director of the Division of Healthcare Policy for the Office of the Assistant Secretary of Preparedness and Response at the U.S. Department of Health and Human Services. He leads a team of policy experts in formulating, analyzing and implementing policies to build strong, integrated, and resilient health systems that are prepared to respond to and recover from disasters and public health emergencies. Prior to his federal service, Dr. Margolis was the associate director of the National Registry of Emergency Medical Technicians, a nonprofit organization that serves as the national certification agency for emergency medical services professionals. Dr. Margolis has held leadership positions and faculty appointments at The George Washington University, the University of Pittsburgh, and the Center for Emergency Medicine of Western Pennsylvania. In 2009–2010, Dr. Margolis was the first paramedic to be awarded a Robert Wood Johnson Foundation Health Policy Fellowship, where he served in the Office of Senator John D. Rockefeller. Dr. Margolis has more than 20 years of clinical experience in prehospital emergency medicine, including 12 years as a flight paramedic. He is the author of dozens of publications in a wide array of topics in emergency medicine.
Maria Julia Marinissen, Ph.D., is the director of the Division of International Health Security in the Office of Policy and Planning in the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS). She actively participates in White House National Security Council Interagency Policy Committees on global health security and leads HHS and ASPR participation in bilateral and multilateral partnerships focused on strengthening public health emergency preparedness and response programs, policies, and initiatives. She is the U.S. Liaison to the Global Health Security Initiative, a Ministerial-level effort of the G7 countries, Mexico, the European Commission, and the World Health Organization (WHO). She was founder of and chaired the North American Health Security Working Group, which developed North American Plan for Animal and Pandemic Influenza launched by the leaders of the United States, Mexico, and Canada in 2012. Her division serves as an advisor to the HHS Secretary and the ASPR on international preparedness and response matters, coordinates international communication with health authorities and organizations during public health emergencies, and leads the development and implementation of policy frameworks for international assistance with laboratory samples, medical countermeasures, and emergency medical personnel. She co-led the U.S. donation of antivirals and vaccines during the H1N1 (2009) pandemic to WHO and partner countries, and served as a policy coordinator for the HHS Disaster Leadership Group during the Fukushima nuclear power plant event and the Middle East respiratory syndrome-coronavirus outbreak in the Middle
East. Dr. Marinissen supervises the policy management of the U.S. International Health Regulations (IHR) national focal point (NFP), which also monitors IHR implementation in the United States. In 2016, on behalf of the U.S. government, her team led the self-assessment of U.S. capacities and coordination of the U.S. IHR joint external evaluation. Additionally, she oversees capacity building programs for surveillance, early-warning infectious-disease surveillance, laboratory diagnostics, emergency communications, and IHR NFP strengthening in partner countries across the world. In 2006, she joined the ASPR/Biomedical Advanced Research and Development Authority (BARDA) as a science and technology policy fellow sponsored by the American Association for the Advancement of Science, where she developed requirements and contributed to operational planning for development, acquisition, and distribution of medical countermeasures for biological, radiological, and nuclear threats. She has graduated from the Annenberg Leadership Institute in 2009 and Harvard University’s National Preparedness Leadership Initiative in 2014. Prior to her career in policy, Dr. Marinissen received the prestigious “Ramon y Cajal” award from the Spanish Ministry of Science in 2004 and led a research group at the Universidad Autonoma de Madrid. She served as a fellow and senior research associate at the National Institutes of Health from 1997 until 2003. She completed her Ph.D. and master’s degree in biology at the Universidad Nacional del Sur in Bahia Blanca, Argentina, where she also held teaching positions in general biology and animal physiology. Dr. Marinissen served for 3 years as a U.S. Marine Corps attaché spouse at the U.S. Embassy in Madrid, Spain.
John Osborn, M.Sc., is the operations administrator at the Department of Practice Administration at the Mayo Clinic in Rochester, Minnesota, supporting the Mayo Clinic Care Network and affiliated practices. He is responsible for practice and business development nationwide and provides strategic leadership for e-health products and services. Prior to this assignment, he was the operations manager for general and trauma surgery in the Department of Surgery and administrator of the Mayo Clinic Level 1 and Level 1 Pediatric Trauma Centers. He has been with the Mayo Clinic since 2004. Mr. Osborn also serves as the lead administrator for mass casualty incident planning and response for the Mayo Clinic and is the administrator for business continuity within the affiliated practices. He is currently an assistant professor of Health Care Systems Engineering in the Mayo Clinic College of Medicine. He is an active member of several national organizations, serving on the boards of directors of the Trauma Center Association of America and the Association of Academic Surgical Administrators. He is also a member of the Sector Coordinating Council for health care and public health within the Critical Infrastructure Protection Advisory Committee system and the editorial board of the American Journal of Disaster
Medicine. Mr. Osborn received a B.A. in political science from the University of Notre Dame in 2001 and his M.S. in decision sciences from the London School of Economics and Political Science in 2004.
Lori Peek, Ph.D., is the director of the Natural Hazards Center and professor in the Department of Sociology at the University of Colorado Boulder. She studies vulnerable populations in disasters and has conducted field investigations in the aftermath of the 9/11 terrorist attacks, Hurricane Katrina, the BP oil spill, the Christchurch earthquakes, the Joplin tornado, Superstorm Sandy, and Hurricane Matthew. Dr. Peek is author of Behind the Backlash: Muslim Americans After 9/11, co-editor of Displaced: Life in the Katrina Diaspora, and co-author of Children of Katrina. Behind the Backlash received the Distinguished Book Award from the Midwest Sociological Society and the Best Book Award from the American Sociological Association Section on Altruism, Morality, and Social Solidarity. Children of Katrina received the Best Book Award from the American Sociological Association Section on Children and Youth and the Alfred and Betty McClung Best Book Award from the Association for Humanist Sociologists, and was named a finalist for the Colorado Book Awards. Her work has also appeared in a variety of scholarly outlets, including Disasters, Risk Analysis, Natural Hazards, Natural Hazards Review, International Journal of Mass Emergencies and Disasters, Child Development, Journal of Family Studies, Sociological Inquiry, Qualitative Research, and Children, Youth and Environments. In 2016, Dr. Peek received an honorable mention for the Leo Goodman Award for Outstanding Contributions to Sociological Methodology from the American Sociological Association Section on Methodology. In 2009, the American Sociological Association Section on Children and Youth honored her with the Early Career Award for Outstanding Scholarship. Dr. Peek is past chair of the American Sociological Association Section on Environment and Technology and is currently the president of the Research Committee on Disasters for the International Sociological Association. She is a board member for the William Averette Anderson Fund, which is dedicated to increasing the number of underrepresented professionals in hazards and disaster research and practice. She is also an appointed member of the National Academies of Sciences, Engineering, and Medicine’s Resilient America Roundtable, a member of the oversight committee for the Mitigation Saves study, and a member of the Advisory Committee on Earthquake Hazards Reduction for the National Earthquake Hazards Reduction Program. Dr. Peek earned her Ph.D. in sociology from the University of Colorado Boulder in 2005. She was a research assistant at the Natural Hazards Center from 1999–2005, and a faculty member at Colorado State University from 2005–2016.
Stephen C. Redd, M.D., Rear Admiral (RADM), is the director of the Office of Public Health Preparedness and Response (PHPR) at the U.S. Centers for Disease Control and Prevention (CDC). RADM Redd is responsible for all of CDC’s PHPR activities. PHPR provides strategic direction, support, and coordination for these activities across CDC as well as with local, state, tribal, national, territorial, and international public health partners. PHPR carries out its mission by emphasizing accountability through performance, progress through public health science, and collaboration through partnerships. RADM Redd received his baccalaureate degree in history in 1979 from Princeton University and his medical degree with honors in 1983 at the Emory University School of Medicine. He trained in medicine at the Johns Hopkins Hospital and completed the 2-year Epidemic Intelligence Service training program at CDC. Prior to joining PHPR, RADM Redd was the director of CDC’s Influenza Coordination Unit. As a medical epidemiologist, RADM Redd managed and directed CDC’s efforts to prepare and respond to pandemic influenza—a severe influenza pandemic could cause as many as 2 million deaths in the United States and tens of millions of deaths worldwide. As a career officer, RADM Redd served as an officer in the Junior Commissioned Officer Student Training and Extern Program while in medical school and returned to the Public Health Service following medical training. He has more than 29 years of continuous service as a commissioned officer and has undertaken work as diverse as investigating outbreaks of Legionnaires’ disease, to devising diagnosis and treatment strategies for malaria in Africa, to leading efforts to eliminate measles from the United States. Before his current assignment as director of the Influenza Coordination Unit, RADM Redd led CDC’s efforts to reduce the burden of asthma in the United States in CDC’s National Center of Environmental Health. When the H1N1 pandemic struck, RADM Redd served as the incident commander for CDC’s 11-month response, which involved more than 3,000 CDC staff and resulted in the vaccination of more than 80 million Americans against the H1N1 influenza virus. RADM Redd is board certified in internal medicine, a fellow of the American College of Physicians, and a member of the Commissioned Officer’s Association. RADM Redd has authored more than 120 scientific publications, including original peer-reviewed research, textbook chapters, and editorials. His research has spanned the gamut from evaluating the impact of air pollution regulations on deaths from carbon monoxide poisoning to the clinical diagnosis of malaria and pneumonia. RADM Redd has received numerous public health service awards, including the Distinguished Service Medal and the Meritorious Service Medal, and is a member of the Alpha Omega Alpha medical honor society. He has been nominated three times and once won CDC’s annual Shepard Award for outstanding scientific publications at CDC.
Irwin Redlener, M.D., is a recognized national leader in disaster preparedness and the public health ramifications of terrorism and large-scale catastrophic events. He and his team have developed major programs to enhance public health and health system readiness with respect to disasters. He has written and spoken widely on the response to Hurricane Katrina, U.S. readiness for pandemics, and the concerns of children as potential targets of terrorism. Dr. Redlener has also had more than three decades of experience providing health care to medically underserved children in rural and urban communities throughout the United States. As founder and president of the Children’s Health Fund, he is a renowned advocate for access to health care for all children. Dr. Redlener served as a principal developer and president of the new Children’s Hospital at Montefiore in the Bronx. He has been a formal and informal adviser to the president and various cabinet members since 1993 and over the past few years has been working with key members of the U.S. Congress on disaster preparedness and child health access. In 1993 and 1994, Dr. Redlener served as a special consultant to the National Health Reform Task Force for the Clinton White House. He has taught medical students in rural Honduras and has led or assisted in international disaster relief in Central America and Africa. Dr. Redlener has also created a series of direct medical relief programs and public health initiatives in the Gulf region ravaged by Hurricane Katrina.
Laura Runnels, M.P.H., is a strategist and facilitator with LAR Consulting, a Washington, DC-based consulting firm. She has more than 12 years of experience providing capacity-building assistance, training, and coaching to local, state, and federal clients. She is known for designing and facilitating highly collaborative, efficient, and productive meetings, workshops, and trainings. As a strategist, she guides individuals, organizations, and coalitions through technical and adaptive challenges. Ms. Runnels holds a master’s degree from Saint Louis University and completed her undergraduate studies at Yale University.
Timothy L. Sellnow, Ph.D., is a professor of strategic communication at the Nicholson School of Communication at the University of Central Florida. Dr. Sellnow’s research focuses on biosecurity, pre-crisis planning, and strategic communication for risk management and mitigation in government, organizational, and health settings. He has conducted funded research for the U.S. Department of Homeland Security, the U.S. Department of Agriculture, the U.S. Centers for Disease Control and Prevention, the U.S. Environmental Protection Agency, and the U.S. Geological Survey. He has also served in an advisory role for the National Academy of Sciences and the World Health Organization. He has published numerous refereed journal articles on risk and crisis communication and has co-authored five books
on risk and crisis communication. Dr. Sellnow’s most recent book is titled Narratives of Crisis: Telling Stories of Ruin and Renewal. Dr. Sellnow is a recipient of the National Communication Association’s Gerald M. Phillips award for Distinguished Applied Communication Research.
Umair A. Shah, M.D., M.P.H., was appointed as the Harris County Public Health (HCPH) executive director and local health authority for Harris County, Texas, the third most populous county in the United States, in May 2013. Since 2004, he served as the HCPH deputy director and director of Disease Control and Clinical Prevention. Prior to joining HCPH he provided clinical care as an emergency department physician at the well-respected Michael E. DeBakey Veterans Affairs Medical Center and chief medical officer at the Galveston County Health District. He earned his B.A. in philosophy from Vanderbilt University and his M.D. from the University of Toledo Health Science Center, where he also completed an international health policy internship at the World Health Organization (Geneva). Dr. Shah completed his internal medicine residency, primary care/general medicine fellowship, and his M.P.H. in management at the University of Texas Health Science Center. Dr. Shah has had a long, distinguished career in public service, having served in numerous leadership positions and having responded to a variety of large-scale emergencies. These include Tropical Storm Allison; Hurricanes Katrina, Rita, and Ike; earthquakes in Kashmir and Haiti; and novel H1N1, Ebola, and Zika outbreaks. Though he is sought nationally for his expertise, Dr. Shah remains actively engaged in both local patient care and academic teaching.
Lee Stevens serves in the Office of the National Coordinator as the division director for state policy, overseeing the development and dissemination of policies intended to support the electronic exchange of health information. Mr. Stevens has also served as the manager of the health information exchange (HIE) plan development and oversight for the Eastern and Southern regions of the United States, Puerto Rico, and the Virgin Islands, including technical assistance and long-term planning activities related to enabling exchange. Mr. Stevens also serves as the liaison for intergovernmental affairs on issues related to health information technology (HIT) for the Office of the Secretary. Before coming to the U.S. Department of Health and Human Services, Mr. Stevens served as the federal policy director for the Southern Governors’ Association where he managed the Gulf Coast HIT Task Force. The Gulf Coast HIT Task Force was created to establish a dialogue on HIE between states impacted by Hurricanes Katrina and Rita. Mr. Stevens has also served as the Washington, DC-based health and human services advisor for North Carolina Governor Jim Hunt and previously as a senior legislative assistant on health issues for former U.S. Congressman Charlie Rose.
Mitch Stripling, M.P.A., oversees agency preparedness efforts at the New York City (NYC) Department of Health and Mental Hygiene, including units for planning, training and exercise operations, and evaluations. He coordinated citywide planning for the 2009 H1N1 pandemic and served as a planning section chief at the department for the responses to Hurricanes Irene and Sandy, the Ebola crisis, and the recent outbreaks of Legionella and Zika. His program also manages the city’s current effort to mount a massive canvassing effort after future disasters. His unit has developed nationally recognized threat response guides for 21 of the highest risk scenarios that could impact NYC, a data- and consensus-driven risk assessment methodology, a principal scientific advisor model for public health incident command system, and a strategic planning directive model for civilian use. Prior to working in NYC, Mr. Stripling worked for the Florida Department of Health. There, he helped plan and implement the responses to six federally declared disasters, including the 2004 record-breaking hurricane season and Florida’s response in southern Mississippi after Hurricane Katrina. During that time, he developed, rostered, and trained environmental health and other public health strike teams, built national training standards in collaboration with the U.S. Centers for Disease Control and Prevention, and focused on making communities more resilient in the face of environmental threats. Before working in public health, he spent several years providing strategic consulting for Fortune 500 companies and government agencies. He began his career working at the United Nations Global Teaching and Learning Project on human rights issues.
W. Craig Vanderwagen, M.D., Rear Admiral (RADM), serves as the co-founder and director of East West Protection, LLC. Dr. Vanderwagen served for 28 years as a uniformed officer in the U.S. Public Health Service, retiring with the rank of rear admiral (upper half). He served for 25 years in the Indian Health Service. His last assignment was as the presidentially appointed and Senate confirmed Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services. He also serves as a senior partner with Martin, Blanck and Associates, a professional consulting firm located in Alexandria, Virginia. As the founding ASPR, he implemented new federal legislation that established ASPR as the principal leader for all federal public health and medical response activities to any deliberate or natural disasters in the United States. The legislation established a federal role in the development and utilization of human and other material assets in preparedness and response, as well as systems for deploying and managing these assets in emergency situations. His position also gave him authority and oversight of the federal effort to develop and support a wide range of medical countermeasures (e.g., diagnostics, vaccines, therapeutic drugs, and biologics) against chemical, biolo-
gial, radiological, nuclear, and pandemic influenza threats. This oversight responsibility included scientific discovery, product development, licensure, acquisition, and deployment. Dr. Vanderwagen was responsible for the creation of operational plans to address the 15 national threats (including biological threats such as anthrax, smallpox, and plague, as well as threats from nuclear, radiation, and chemical devices, and natural disasters such as hurricanes and earthquakes) supported by appropriate situational awareness, logistics, planning, training, and exercises coordinated through the Secretary’s Command Center, an emergency operations center linked to all other federal, state, and local command centers. Dr. Vanderwagen received his M.D. from the Michigan State University College of Human Medicine. He completed his residency in family medicine at the University of New Mexico and is board certified in family practice medicine. He received his bachelor’s degree from Calvin College.
Laura Wolf, Ph.D., is currently the chief of the Critical Infrastructure Protection Branch of the U.S. Department of Health and Human Services (HHS). She has held various positions within HHS since 2008, including serving as a senior program analyst, science policy advisor, and science policy analyst. From 2007 to 2008, she served as a congressional science fellow on the Senate Health, Education, Labor & Pensions Committee for the American Society of Microbiology. Dr. Wolf is experienced in hospital and public health preparedness, policy analysis, strategic communications, biotechnology, biochemistry, microbiology, immunology and infectious diseases. She holds a doctorate in biological sciences from the University of California, San Diego, and a B.S. in biology from the Massachusetts Institute of Technology.
This page intentionally left blank.